Abstract
Pancreatitis remains one of the most serious post-endoscopic retrograde cholangiopancretograpy (ERCP) complications. Previous meta-analyses show that prophylactic pancreatic duct (PD) stent placement reduces the risk of post-ERCP pancreatitis (PEP) in both high-risk and low-risk patients (pts). There is only one prior report of urgent ERCP and PD stent placement against PEP (Madácsy L, et al. Surg Endosc 2009).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
